Latest News & Features
Patents
India’s Supreme Court has rejected pharmaceutical company Novartis’s application to patent an updated version of its leukaemia drug Glivec, agreeing with the Comptroller General that it lacked novelty. 3 April 2013
Patents
In an international context, the landscape for licensing of Australian patents is relatively straightforward, but there are some issues peculiar to Australia that should not be overlooked when considering licensing
arrangements. John Walker explains. 1 April 2013
Patents
Intellectual Property Exchange International is the world’s first financial exchange for licensing and trading IP rights. WIPR spoke to CEO Gerard Pannekoek about why he believes it will encourage innovation and reduce patent litigation. 1 April 2013
Patents
Patents County Court presiding judge Colin Birss spoke to WIPR about the success of the court that gives SMEs a fighting chance against the big guns in IP disputes. 1 April 2013
Trademarks
The trademark community experienced major global policy developments in 2012, from the accession
of countries in Latin America to the Madrid Protocol to Myanmar’s first trademark law. At each turn, INTA was
active on behalf of trademark owners. 1 April 2013
Jurisdiction reports
Significant changes to both the Canadian Trade-marks Act and the Copyright Act may be coming in the near future. 1 April 2013
Jurisdiction reports
In the case of Ho Tack Sien & Ors v Rotta Research Laboratorium SpA & Anor, the respondent manufactured a drug called Viartril-S (glucosamine sulphate) used in the treatment of osteoarthritis. 1 April 2013
Jurisdiction reports
On February 20, 2013, the US Supreme Court surprised many members of the US bar by holding in the decision of Gunn v Minton that federal courts do not have exclusive subject matter jurisdiction over claims asserting patent malpractice. 1 April 2013
Jurisdiction reports
This article does not intend to provide yet another comment on the issue of using community trademarks (CTMs) in one or more countries since the Onel decision has made it clear that use of a CTM is not dependent on national boundaries. 1 April 2013
Jurisdiction reports
France has implemented EU Directive 2011/62/UE June 8, 2011 relating to medicinal products for human use, by enacting an ordinance of December 19, 2012 and a Decree No. 2012-1562 of December 31, 2012. 1 April 2013
Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.